Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10900.00x is in line with its 5-year average of -10634.22x, around the middle of its 5-year range (-21208.00x–-3.22x).
As of the fiscal period ended Saturday, September 30, 2023. 38.87% above its 12-month average of -17829.55x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2023 (2023-09-30): -10900.00x.
INTEREST COVERAGE RATIO
-10900.00x
INTEREST COVERAGE RATIO AVG TTM
-17829.55x
INTEREST COVERAGE RATIO AVG 3Y
-14623.54x
INTEREST COVERAGE RATIO AVG 5Y
-10634.22x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+38.87%
CURRENT VS 3Y AVG
+25.46%
CURRENT VS 5Y AVG
-2.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-169154.66%
vs the sector median at left
Kodiak Sciences Inc.
Market Cap
$5.78B
Interest Coverage Ratio
-10900.00x
TTM Avg
-17829.55x
3Y Avg
-14623.54x
5Y Avg
-10634.22x
Market Cap
$5.79B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.87B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.95B
Interest Coverage Ratio
10.01x
TTM Avg
10.01x
3Y Avg
9.97x
5Y Avg
7.31x
Market Cap
$5.53B
Interest Coverage Ratio
1.30x
TTM Avg
1.31x
3Y Avg
1.26x
5Y Avg
1.25x
Market Cap
$5.52B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.23B
Interest Coverage Ratio
-9.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | $5.78B | -10900.00x | -17829.55x | -14623.54x | -10634.22x |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | N/A | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | N/A | N/A | N/A | N/A |
| GRAIL Inc. (GRAL)vs › | $5.89B | N/A | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.61B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 10.01x | 10.01x | 9.97x | 7.31x |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.30x | 1.31x | 1.26x | 1.25x |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | N/A | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | -9.33x | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 5.63x | 5.63x | 5.63x | 5.63x |
Interest Coverage
-10900.0x
Debt/Equity
1.57
Current Ratio
2.49
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-09-30 | -10900.00x |
| 2023-06-30 | -21208.00x |
| 2023-03-31 | -18653.75x |
| 2022-12-31 | -18516.50x |
| 2022-09-30 | -19869.50x |
| 2022-06-30 | -18413.60x |
| 2022-03-31 | -19153.40x |
| 2021-12-31 | -18609.80x |
| 2021-09-30 | -11255.83x |
| 2021-06-30 | -11181.80x |
| 2021-03-31 | -8426.33x |
| 2020-12-31 | -7807.00x |
| 2020-09-30 | -6110.50x |
| 2020-06-30 | -4463.17x |
| 2020-03-31 | -3674.71x |
| 2019-09-30 | -6366.00x |
| 2019-06-30 | -5907.00x |
| 2019-03-31 | -2115.00x |
| 2018-12-31 | -49.25x |
| 2018-09-30 | -3.22x |
| 2018-06-30 | -2.71x |
| 2018-03-31 | -3.77x |
| 2017-12-31 | -12.54x |
| 2017-09-30 | -10.07x |
